Request for Covid-19 Impact Assessment of this Report
The United States Transthyretin Stabilizer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Transthyretin Stabilizer market, reaching US$ million by the year 2028. As for the Europe Transthyretin Stabilizer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Transthyretin Stabilizer players cover Pfizer Inc., Merck & Co., AstraZeneca Plc., and GlaxoSmithKline Plc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin Stabilizer market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diflunisal
Tafamidis
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transthyretin Stabilizer Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transthyretin Stabilizer by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transthyretin Stabilizer by Country/Region, 2017, 2022 & 2028
2.2 Transthyretin Stabilizer Segment by Type
2.2.1 Diflunisal
2.2.2 Tafamidis
2.2.3 Others
2.3 Transthyretin Stabilizer Sales by Type
2.3.1 Global Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
2.3.2 Global Transthyretin Stabilizer Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transthyretin Stabilizer Sale Price by Type (2017-2022)
2.4 Transthyretin Stabilizer Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Online Pharmacies
2.4.5 Others
2.5 Transthyretin Stabilizer Sales by Application
2.5.1 Global Transthyretin Stabilizer Sale Market Share by Application (2017-2022)
2.5.2 Global Transthyretin Stabilizer Revenue and Market Share by Application (2017-2022)
2.5.3 Global Transthyretin Stabilizer Sale Price by Application (2017-2022)
3 Global Transthyretin Stabilizer by Company
3.1 Global Transthyretin Stabilizer Breakdown Data by Company
3.1.1 Global Transthyretin Stabilizer Annual Sales by Company (2020-2022)
3.1.2 Global Transthyretin Stabilizer Sales Market Share by Company (2020-2022)
3.2 Global Transthyretin Stabilizer Annual Revenue by Company (2020-2022)
3.2.1 Global Transthyretin Stabilizer Revenue by Company (2020-2022)
3.2.2 Global Transthyretin Stabilizer Revenue Market Share by Company (2020-2022)
3.3 Global Transthyretin Stabilizer Sale Price by Company
3.4 Key Manufacturers Transthyretin Stabilizer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transthyretin Stabilizer Product Location Distribution
3.4.2 Players Transthyretin Stabilizer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transthyretin Stabilizer by Geographic Region
4.1 World Historic Transthyretin Stabilizer Market Size by Geographic Region (2017-2022)
4.1.1 Global Transthyretin Stabilizer Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transthyretin Stabilizer Annual Revenue by Geographic Region
4.2 World Historic Transthyretin Stabilizer Market Size by Country/Region (2017-2022)
4.2.1 Global Transthyretin Stabilizer Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transthyretin Stabilizer Annual Revenue by Country/Region
4.3 Americas Transthyretin Stabilizer Sales Growth
4.4 APAC Transthyretin Stabilizer Sales Growth
4.5 Europe Transthyretin Stabilizer Sales Growth
4.6 Middle East & Africa Transthyretin Stabilizer Sales Growth
5 Americas
5.1 Americas Transthyretin Stabilizer Sales by Country
5.1.1 Americas Transthyretin Stabilizer Sales by Country (2017-2022)
5.1.2 Americas Transthyretin Stabilizer Revenue by Country (2017-2022)
5.2 Americas Transthyretin Stabilizer Sales by Type
5.3 Americas Transthyretin Stabilizer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin Stabilizer Sales by Region
6.1.1 APAC Transthyretin Stabilizer Sales by Region (2017-2022)
6.1.2 APAC Transthyretin Stabilizer Revenue by Region (2017-2022)
6.2 APAC Transthyretin Stabilizer Sales by Type
6.3 APAC Transthyretin Stabilizer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transthyretin Stabilizer by Country
7.1.1 Europe Transthyretin Stabilizer Sales by Country (2017-2022)
7.1.2 Europe Transthyretin Stabilizer Revenue by Country (2017-2022)
7.2 Europe Transthyretin Stabilizer Sales by Type
7.3 Europe Transthyretin Stabilizer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transthyretin Stabilizer by Country
8.1.1 Middle East & Africa Transthyretin Stabilizer Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transthyretin Stabilizer Revenue by Country (2017-2022)
8.2 Middle East & Africa Transthyretin Stabilizer Sales by Type
8.3 Middle East & Africa Transthyretin Stabilizer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin Stabilizer
10.3 Manufacturing Process Analysis of Transthyretin Stabilizer
10.4 Industry Chain Structure of Transthyretin Stabilizer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transthyretin Stabilizer Distributors
11.3 Transthyretin Stabilizer Customer
12 World Forecast Review for Transthyretin Stabilizer by Geographic Region
12.1 Global Transthyretin Stabilizer Market Size Forecast by Region
12.1.1 Global Transthyretin Stabilizer Forecast by Region (2023-2028)
12.1.2 Global Transthyretin Stabilizer Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transthyretin Stabilizer Forecast by Type
12.7 Global Transthyretin Stabilizer Forecast by Application
13 Key Players Analysis
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Transthyretin Stabilizer Product Offered
13.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Merck & Co.
13.2.1 Merck & Co. Company Information
13.2.2 Merck & Co. Transthyretin Stabilizer Product Offered
13.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck & Co. Main Business Overview
13.2.5 Merck & Co. Latest Developments
13.3 AstraZeneca Plc.
13.3.1 AstraZeneca Plc. Company Information
13.3.2 AstraZeneca Plc. Transthyretin Stabilizer Product Offered
13.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Plc. Main Business Overview
13.3.5 AstraZeneca Plc. Latest Developments
13.4 GlaxoSmithKline Plc.
13.4.1 GlaxoSmithKline Plc. Company Information
13.4.2 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Offered
13.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GlaxoSmithKline Plc. Main Business Overview
13.4.5 GlaxoSmithKline Plc. Latest Developments
13.5 Corino Therapeutics Inc.
13.5.1 Corino Therapeutics Inc. Company Information
13.5.2 Corino Therapeutics Inc. Transthyretin Stabilizer Product Offered
13.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Corino Therapeutics Inc. Main Business Overview
13.5.5 Corino Therapeutics Inc. Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Offered
13.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Bellus Health Inc.
13.7.1 Bellus Health Inc. Company Information
13.7.2 Bellus Health Inc. Transthyretin Stabilizer Product Offered
13.7.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bellus Health Inc. Main Business Overview
13.7.5 Bellus Health Inc. Latest Developments
13.8 Ionis Pharmaceuticals, Inc.
13.8.1 Ionis Pharmaceuticals, Inc. Company Information
13.8.2 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Offered
13.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.8.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.9 Proclara Bioscience
13.9.1 Proclara Bioscience Company Information
13.9.2 Proclara Bioscience Transthyretin Stabilizer Product Offered
13.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Proclara Bioscience Main Business Overview
13.9.5 Proclara Bioscience Latest Developments
13.10 Arturus Therapeutics
13.10.1 Arturus Therapeutics Company Information
13.10.2 Arturus Therapeutics Transthyretin Stabilizer Product Offered
13.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Arturus Therapeutics Main Business Overview
13.10.5 Arturus Therapeutics Latest Developments
13.11 Prothena Corporation Plc.
13.11.1 Prothena Corporation Plc. Company Information
13.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Product Offered
13.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Prothena Corporation Plc. Main Business Overview
13.11.5 Prothena Corporation Plc. Latest Developments
14 Research Findings and Conclusion
Table 1. Transthyretin Stabilizer Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transthyretin Stabilizer Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diflunisal
Table 4. Major Players of Tafamidis
Table 5. Major Players of Others
Table 6. Global Transthyretin Stabilizer Sales by Type (2017-2022) & (K Units)
Table 7. Global Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
Table 8. Global Transthyretin Stabilizer Revenue by Type (2017-2022) & ($ million)
Table 9. Global Transthyretin Stabilizer Revenue Market Share by Type (2017-2022)
Table 10. Global Transthyretin Stabilizer Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Transthyretin Stabilizer Sales by Application (2017-2022) & (K Units)
Table 12. Global Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Table 13. Global Transthyretin Stabilizer Revenue by Application (2017-2022)
Table 14. Global Transthyretin Stabilizer Revenue Market Share by Application (2017-2022)
Table 15. Global Transthyretin Stabilizer Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Transthyretin Stabilizer Sales by Company (2020-2022) & (K Units)
Table 17. Global Transthyretin Stabilizer Sales Market Share by Company (2020-2022)
Table 18. Global Transthyretin Stabilizer Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Transthyretin Stabilizer Revenue Market Share by Company (2020-2022)
Table 20. Global Transthyretin Stabilizer Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Transthyretin Stabilizer Producing Area Distribution and Sales Area
Table 22. Players Transthyretin Stabilizer Products Offered
Table 23. Transthyretin Stabilizer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Transthyretin Stabilizer Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Transthyretin Stabilizer Sales Market Share Geographic Region (2017-2022)
Table 28. Global Transthyretin Stabilizer Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Transthyretin Stabilizer Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Transthyretin Stabilizer Sales Market Share by Country/Region (2017-2022)
Table 32. Global Transthyretin Stabilizer Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Transthyretin Stabilizer Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Transthyretin Stabilizer Sales by Country (2017-2022) & (K Units)
Table 35. Americas Transthyretin Stabilizer Sales Market Share by Country (2017-2022)
Table 36. Americas Transthyretin Stabilizer Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Transthyretin Stabilizer Revenue Market Share by Country (2017-2022)
Table 38. Americas Transthyretin Stabilizer Sales by Type (2017-2022) & (K Units)
Table 39. Americas Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
Table 40. Americas Transthyretin Stabilizer Sales by Application (2017-2022) & (K Units)
Table 41. Americas Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Table 42. APAC Transthyretin Stabilizer Sales by Region (2017-2022) & (K Units)
Table 43. APAC Transthyretin Stabilizer Sales Market Share by Region (2017-2022)
Table 44. APAC Transthyretin Stabilizer Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Transthyretin Stabilizer Revenue Market Share by Region (2017-2022)
Table 46. APAC Transthyretin Stabilizer Sales by Type (2017-2022) & (K Units)
Table 47. APAC Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
Table 48. APAC Transthyretin Stabilizer Sales by Application (2017-2022) & (K Units)
Table 49. APAC Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Table 50. Europe Transthyretin Stabilizer Sales by Country (2017-2022) & (K Units)
Table 51. Europe Transthyretin Stabilizer Sales Market Share by Country (2017-2022)
Table 52. Europe Transthyretin Stabilizer Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Transthyretin Stabilizer Revenue Market Share by Country (2017-2022)
Table 54. Europe Transthyretin Stabilizer Sales by Type (2017-2022) & (K Units)
Table 55. Europe Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
Table 56. Europe Transthyretin Stabilizer Sales by Application (2017-2022) & (K Units)
Table 57. Europe Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Transthyretin Stabilizer Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Transthyretin Stabilizer Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Transthyretin Stabilizer Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Transthyretin Stabilizer Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Transthyretin Stabilizer
Table 67. Key Market Challenges & Risks of Transthyretin Stabilizer
Table 68. Key Industry Trends of Transthyretin Stabilizer
Table 69. Transthyretin Stabilizer Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Transthyretin Stabilizer Distributors List
Table 72. Transthyretin Stabilizer Customer List
Table 73. Global Transthyretin Stabilizer Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Transthyretin Stabilizer Sales Market Forecast by Region
Table 75. Global Transthyretin Stabilizer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Transthyretin Stabilizer Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Transthyretin Stabilizer Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Transthyretin Stabilizer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Transthyretin Stabilizer Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Transthyretin Stabilizer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Transthyretin Stabilizer Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Transthyretin Stabilizer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Transthyretin Stabilizer Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Transthyretin Stabilizer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Transthyretin Stabilizer Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Transthyretin Stabilizer Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Transthyretin Stabilizer Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Transthyretin Stabilizer Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Transthyretin Stabilizer Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Transthyretin Stabilizer Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Transthyretin Stabilizer Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Transthyretin Stabilizer Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Inc. Transthyretin Stabilizer Product Offered
Table 95. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Pfizer Inc. Main Business
Table 97. Pfizer Inc. Latest Developments
Table 98. Merck & Co. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck & Co. Transthyretin Stabilizer Product Offered
Table 100. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Merck & Co. Main Business
Table 102. Merck & Co. Latest Developments
Table 103. AstraZeneca Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Plc. Transthyretin Stabilizer Product Offered
Table 105. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. AstraZeneca Plc. Main Business
Table 107. AstraZeneca Plc. Latest Developments
Table 108. GlaxoSmithKline Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Plc. Transthyretin Stabilizer Product Offered
Table 110. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. GlaxoSmithKline Plc. Main Business
Table 112. GlaxoSmithKline Plc. Latest Developments
Table 113. Corino Therapeutics Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 114. Corino Therapeutics Inc. Transthyretin Stabilizer Product Offered
Table 115. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Corino Therapeutics Inc. Main Business
Table 117. Corino Therapeutics Inc. Latest Developments
Table 118. Alnylam Pharmaceuticals Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 119. Alnylam Pharmaceuticals Transthyretin Stabilizer Product Offered
Table 120. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Alnylam Pharmaceuticals Main Business
Table 122. Alnylam Pharmaceuticals Latest Developments
Table 123. Bellus Health Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 124. Bellus Health Inc. Transthyretin Stabilizer Product Offered
Table 125. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Bellus Health Inc. Main Business
Table 127. Bellus Health Inc. Latest Developments
Table 128. Ionis Pharmaceuticals, Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 129. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Offered
Table 130. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Ionis Pharmaceuticals, Inc. Main Business
Table 132. Ionis Pharmaceuticals, Inc. Latest Developments
Table 133. Proclara Bioscience Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 134. Proclara Bioscience Transthyretin Stabilizer Product Offered
Table 135. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Proclara Bioscience Main Business
Table 137. Proclara Bioscience Latest Developments
Table 138. Arturus Therapeutics Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 139. Arturus Therapeutics Transthyretin Stabilizer Product Offered
Table 140. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Arturus Therapeutics Main Business
Table 142. Arturus Therapeutics Latest Developments
Table 143. Prothena Corporation Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 144. Prothena Corporation Plc. Transthyretin Stabilizer Product Offered
Table 145. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Prothena Corporation Plc. Main Business
Table 147. Prothena Corporation Plc. Latest Developments
List of Figures
Figure 1. Picture of Transthyretin Stabilizer
Figure 2. Transthyretin Stabilizer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin Stabilizer Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Transthyretin Stabilizer Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transthyretin Stabilizer Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diflunisal
Figure 10. Product Picture of Tafamidis
Figure 11. Product Picture of Others
Figure 12. Global Transthyretin Stabilizer Sales Market Share by Type in 2021
Figure 13. Global Transthyretin Stabilizer Revenue Market Share by Type (2017-2022)
Figure 14. Transthyretin Stabilizer Consumed in Hospital Pharmacies
Figure 15. Global Transthyretin Stabilizer Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Transthyretin Stabilizer Consumed in Retail Pharmacies
Figure 17. Global Transthyretin Stabilizer Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Transthyretin Stabilizer Consumed in Drug Stores
Figure 19. Global Transthyretin Stabilizer Market: Drug Stores (2017-2022) & (K Units)
Figure 20. Transthyretin Stabilizer Consumed in Online Pharmacies
Figure 21. Global Transthyretin Stabilizer Market: Online Pharmacies (2017-2022) & (K Units)
Figure 22. Transthyretin Stabilizer Consumed in Others
Figure 23. Global Transthyretin Stabilizer Market: Others (2017-2022) & (K Units)
Figure 24. Global Transthyretin Stabilizer Sales Market Share by Application (2017-2022)
Figure 25. Global Transthyretin Stabilizer Revenue Market Share by Application in 2021
Figure 26. Transthyretin Stabilizer Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Transthyretin Stabilizer Revenue Market Share by Company in 2021
Figure 28. Global Transthyretin Stabilizer Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region in 2021
Figure 30. Global Transthyretin Stabilizer Sales Market Share by Region (2017-2022)
Figure 31. Global Transthyretin Stabilizer Revenue Market Share by Country/Region in 2021
Figure 32. Americas Transthyretin Stabilizer Sales 2017-2022 (K Units)
Figure 33. Americas Transthyretin Stabilizer Revenue 2017-2022 ($ Millions)
Figure 34. APAC Transthyretin Stabilizer Sales 2017-2022 (K Units)
Figure 35. APAC Transthyretin Stabilizer Revenue 2017-2022 ($ Millions)
Figure 36. Europe Transthyretin Stabilizer Sales 2017-2022 (K Units)
Figure 37. Europe Transthyretin Stabilizer Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Transthyretin Stabilizer Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Transthyretin Stabilizer Revenue 2017-2022 ($ Millions)
Figure 40. Americas Transthyretin Stabilizer Sales Market Share by Country in 2021
Figure 41. Americas Transthyretin Stabilizer Revenue Market Share by Country in 2021
Figure 42. United States Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Transthyretin Stabilizer Sales Market Share by Region in 2021
Figure 47. APAC Transthyretin Stabilizer Revenue Market Share by Regions in 2021
Figure 48. China Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Transthyretin Stabilizer Sales Market Share by Country in 2021
Figure 55. Europe Transthyretin Stabilizer Revenue Market Share by Country in 2021
Figure 56. Germany Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country in 2021
Figure 63. Egypt Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Transthyretin Stabilizer Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Transthyretin Stabilizer in 2021
Figure 69. Manufacturing Process Analysis of Transthyretin Stabilizer
Figure 70. Industry Chain Structure of Transthyretin Stabilizer
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...